Initiate Phase 3 studies for subcutaneous VK2735 for obesity
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 30 Jun 2025
- Delivered
- 25 Jun 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25”
What we found
Evidence strength B What the grades mean
Viking Therapeutics initiated the Phase 3 VANQUISH clinical program for subcutaneous VK2735 in obesity on June 25, 2025, within the stated 2Q25 deadline.
-
B Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735 Company press release announcing Phase 3 VANQUISH program initiation
-
D Viking commences Phase III clinical programme of VK2735 for obesity Independent news confirming Phase 3 VANQUISH program commencement
-
D Obesity drug VK2735 drives Viking Therapeutics (VKTX) big 2025 R&D ramp CEO confirms Phase 3 VANQUISH program initiated in June 2025
Checked 12 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Viking Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-VKTX-000236 · Corrections policy